| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Group President, Adtalem Health | Gr President Medical and Healthcare | SVP, Medical and Healthcare +1 more
1 company
Holland Katherine Alice Boden last filed a Form 4 in August 2021, as Group President, Adtalem Health at ATGE. Holland Katherine Alice Boden's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 32,148 shares of ATGE. Net of sales, the ATGE filings show accumulation of 2,611 shares.
Holland Katherine Alice Boden has 18 Form 4 filings on record from November 2017 to August 2021, all as Group President, Adtalem Health at Adtalem Global Education (ATGE), 2017–2021.
The 25 reported transactions were 12 tax withholdings, 7 stock awards, 4 option or other derivative awards and 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $89K and no sales.
The largest open-market purchase was 2,000 shares of ATGE at an average $31.99 on November 11, 2019, about $64K.
Shares as reported in the last Form 4 for each company; the most recent is from August 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.